Results 71 to 80 of about 555,561 (261)
Frontiers in Integrative NeuroscienceIntroductionCancer is a debilitating disease with an often chronic course. One of the most taxing and prevalent sequelae in this context is cancer-related fatigue (CRF) resulting from the disease and/or associated treatments.
Eliane Timm +4 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko +19 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol +6 more
wiley +1 more source
Recommended natural products in Alzheimer\'s disease based on traditional Persian medicine
Journal of Medicinal Plants, 2020 Background: Alzheimerchr('39')s disease is the most common cause of dementia, especially in elderlies. Its exact pathogenesis is not yet known and existing therapies do not have enough efficacy.
Amir Hossein Jamshidi +5 more
doaj
Complementary Medicine and Evidence
Annals of the Academy of Medicine Singapore, 2000 While clinical medicine is increasingly governed by demands for evidence-based practice and biomedical research increasingly moves towards molecular approaches in the search for new treatments, the public is moving in a different direction—one where science is not the starting point for decision making.
openaire +2 more sources
Ethics of complementary medicine [PDF]
British Journal of General Practice, 2009 Professor Ernst's discussion piece on the ethics of complementary and alternative medicine1 leaves much to be desired as Brian Buckley suggests.2 While statutory regulation is certainly no panacea, it does enable the professions to consider how they can provide their services in a proper and ethical …
openaire +2 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Medication nonadherence during the first 100 days after pediatric hematopoietic stem cell transplantation (HSCT) and during oncology treatment increases risk for complications. BMT4me is a caregiver‐facing mobile health (mHealth) application providing medication reminders, symptom tracking, and note‐taking features to support ...
Micah A. Skeens +4 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen +21 more
wiley +1 more source
The future of integrative health and medicine in Saudi Arabia
Integrative Medicine Research, 2018 Saudi Arabia is witnessing a healthcare transformation to face the challenges of the increased burden of noncommunicable diseases and to maintain the quality of healthcare services.
Mohamed K.M. Khalil +3 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Purpose Despite 5‐year survival rates of over 90% among children and adolescents/young adults (CAYAs) with classic Hodgkin lymphoma (cHL), 15%–20% relapse after frontline therapy. Prior analysis of frontline Children's Oncology Group (COG) clinical trials demonstrated that, despite similar rates of relapse, non‐Hispanic Black (NHB) and ...
Mallorie B. Heneghan +14 more
wiley +1 more source